Latest / Diabetes Connections | Type 1 Diabetes
Ypsomed: Bringing A New Insulin Pump (and Partnership) to the US
For the first time in several years, a new pump company is making a reach into the US market. Meet Ypsomed, the Swiss company teaming up with Lilly Diabetes. Their device, The YpsoPump, is available in Europe and Canada and has some unique features. But when it launches in the US, likely in 2022, it will only use Lilly insulin. That kind of proprietary design is unique and is raising eyebrows. Stacey talks to Simon Michel, Ypsomed's CEO (she'll talk to Lilly in a separate interview airing in a few weeks).
In Innovations this week, what is an inverse diabetes vaccine? And could you be part of…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.